Australian Pharma Company Announces Plans To Build Cannabis Facility In Malta
“In addition to being used in the production of our GMP-certified pharmaceutical products, this contract extends the medical cannabis market for our company into the supply of medical cannabis flowers to emerging European markets, including Germany.”